Northwestern Mutual Wealth Management’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
Other funds holding PACB
AIM
VCM
NAMA
Northwestern Mutual Wealth Management's PACB Position: Q1 2026 in Review
Northwestern Mutual Wealth Management increased its Pacific Biosciences (PACB) stake by 176% in Q1 2026, buying an estimated $315 and bringing the position to 276 shares worth $364. The position accounts for ﹤0.01% of the portfolio, ranked #3878.
Northwestern Mutual Wealth Management first reported a position in PACB in Q2 2015 and has held it in 19 quarters since. The position peaked at $263K in Q4 2015. 229 funds tracked by Wall St. Rank hold PACB as of Q1 2026.
- Northwestern Mutual Wealth Management held 276 shares of Pacific Biosciences worth $364 as of Q1 2026.
- Northwestern Mutual Wealth Management bought 176 Pacific Biosciences shares in Q1 2026, an estimated $315.
- Pacific Biosciences made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #3878 holding.
- Northwestern Mutual Wealth Management first reported a position in Pacific Biosciences in Q2 2015 and has held it in 19 quarters since.
- Northwestern Mutual Wealth Management's Pacific Biosciences position peaked at $263K in Q4 2015.
- 229 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2026.
Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.